Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
28.41
-0.76 (-2.61%)
Nov 2, 2026, 4:00 PM EST - Market closed
Immunovant Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $45 | Buy | Maintains | $45 | +58.39% | Oct 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $45 | Buy | Maintains | $45 | +58.39% | Oct 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $53 | Buy | Maintains | $53 | +86.55% | Sep 26, 2026 |
| Bernstein | Bernstein | Hold Maintains $37 | Hold | Maintains | $37 | +30.24% | Sep 26, 2026 |
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $41 | Buy | Maintains | $41 | +44.32% | Sep 23, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $66 | Buy | Maintains | $66 | +132.31% | Sep 21, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Reiterates $24 → $40 | Hold | Reiterates | $24 → $40 | +40.80% | Aug 24, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.